Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depsipeptide Alone and With Rituximab/Fludarabine in Relapsed/Refractory Low Grade B-Cell Lymphomas
NCT00079443Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jan 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in follicular lymphoma (FL), small lymphocytic lymphoma (SLL), sponsored by National Cancer Institute. Started Jan 2004; status: terminated.
02
Drugs
romidepsin
03
Conditions
follicular lymphoma (FL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00079443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079443.